Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Metabolic Syndrome

• COMMETS- Combination MCI Metabolic Syndrome
• Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
• Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment
• Study of INV-202 in Patients With Obesity and Metabolic Syndrome
• A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
• High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
• A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
• Akkermansia Muciniphilia and Metabolic Side Effects of ADT
• Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects
• Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
• Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
• Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics
• Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips
• A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.
• Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
• Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome
• Doravirine and Weight Gain in Antiretroviral Naive
• A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-and Multiple-Ascending Subcutaneous Doses of DR10624
• Strawberries and Risk of Diabetes in Adults
• A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
• Extended-Release Tacrolimus Following Liver Transplantation
• Explore the Effect of Gynostemma Pentaphyllum on Patients With Metabolic Syndrome
• Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
• Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome
• Semaglutide 2.4 mg in Patients With Poor Weight-loss
• Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women
• Effect of Losartan or Eprosartan on Fructose Hyperuricemia
• Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
• Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
• Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome
• Clinical Study on Wuling Powder in Treating Metabolic Syndrome of Spleen Deficiency and Dampness
• A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
• Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
• Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
• Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
• Interactions of Medicine and Exercise With Meal Timing
• Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
• Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers
• Developing an Obesity Treatment Program in Family Medicine Clinics
• Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS
• A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
• Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
• Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.
• Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
• A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
• Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Hypertension And Surgery Study: Evaluating the Implementation of a Hypertension Guideline Protocol
• Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans
• MANP in Hypertension and Metabolic Syndrome
• Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
• The Gut Microbiome in Women With Polycystic Ovary Syndrome
• Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
• Caduet and TLC Intervention in Metabolic Syndrome
• Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial
• Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome
• Probiotics and Gut Health
• Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
• Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome
• Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
• Berberine Treat Metabolic Syndrome in Schizophrenia
• Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
• Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
• Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
• Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome
• Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge
• Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
• Exercise Training Effects on Metabolic Syndrome: Interactions With Medication
• Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
• Study of Testosterone vs Placebo in Testicular Cancer Survivors
• Berberine as Adjuvant Treatment for Schizophrenia Patients
• A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
• Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
• Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
• Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome
• Mechanisms of Cerebrovascular Control
• Brown Fat Activation Study
• Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
• Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
• Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
• Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity
• Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
• Liraglutide for HIV-associated Neurocognitive Disorder
• Interventional Bioremediation of Microbiota in Metabolic Syndrome
• Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
• A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
• Metabolic Effects of Angiotensin-(1-7)
• Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
• Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
• Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome
• Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome
• Cold Induced Changes in White Adipose
• Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome
• Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause
• Oral Nitrite Trial for Hypertension and Metabolic Syndrome
• Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes
• Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
• Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
• Phlebotomy and Polycystic Ovary Syndrome
• Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin
• Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers
• Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome
• Galantamine Effects in Patients With Metabolic Syndrome
• Mesoglycan, Vascular Reactivity and Metabolic Syndrome
• Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
• Metformin in Kidney Disease
• Effects of IL-1 Beta on the HPA-axis in Obese Persons
• Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
• Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome
• Blood Lipopolysaccharide (LPS) Rifaximin Study
• Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
• MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism
• Endogenous Opioid Activity and Affective State in Insulin Resistant Women
• Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
• Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
• Metformin in the Diastolic Dysfunction of Metabolic Syndrome
• Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
• Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
• Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol
• Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
• Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status
• Aldosterone Antagonism and Microvascular Function
• GH and Cardiovascular Risk Factors
• Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
• SGA-induced Metabolic Syndrome in Bipolar Youth
• Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study
• The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
• Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
• Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
• Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
• Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
• Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
• Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
• Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
• Exercise, Statins, and the Metabolic Syndrome
• Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
• Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
• Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
• Cortisol and Nutritional Sympathetic Responsiveness
• Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
• Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation Therapy
• Effect of Aged Garlic Extract on Atherosclerosis
• Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
• Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers
• The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
• Hyperinsulinemic Euglycemic Clamp Protocol
• Effect of Lycopene and Isoflavones on Glucose Metabolism
• Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
• Metformin in Postmenopausal Women With Metabolic Syndrome
• Study of Sildenafil Citrate on Insulin Resistance in African American
• Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
• Ranolazine, Ethnicity and the Metabolic Syndrome
• Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
• The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk
• Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers
• Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
• Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
• Effect of Vitamin D on Metabolic Parameters in Patients With the Metabolic Syndrome
• Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
• Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome
• Effect of Magnesium Administration in Subjects With Family History of Diabetes or Metabolic Syndrome
• Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
• Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism
• Hyperuricemia on Hypertension and Metabolic Syndrome
• Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue
• Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
• Treatment of Adiposity Related hypErTension (TARGET)
• Testosterone Replacement in Metabolic Syndrome and Inflammation
• The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome
• One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
• Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice
• Aldosterone and the Metabolic Syndrome
• Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis
• Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
• Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome
• Melatonin and the Metabolic Syndrome
• Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
• A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
• Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
• The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
• Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
• Vascular Effects of Hesperidin in Metabolic Syndrome
• Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
• Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
• Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
• Characterization of Beta Cell Failure
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
• Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
• Regulation of Lipoprotein Transport in Metabolic Syndrome
• Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
• Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
• Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
• The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study
• Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
• Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension
• Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
• Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)
• Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
• Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
• Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
• The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
• Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
• Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
• Regression of Fatty Heart by Valsartan Therapy
• Androgen Deprivation Therapy Study
• Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
• Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
• Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
• A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
• MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)
• Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men
• The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men
• Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
• A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
• Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
• Implications for Treatment of the Metabolic Syndrome
• Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
• The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome
• Effects of Leptin Replacement in Children
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
• Effects of Human Leptin Replacement
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
• Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome
• COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
• Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome
• The Effect of Allopurinol on Insulin Resistance and Blood Pressure
• Exercise and Pioglitazone for HIV-Metabolic Syndromes
• Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
• Pharmacological Regulation of Fat Transport in Metabolic Syndrome
• Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
• Insulin Resistance Study
• Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
• The Autonomic Nervous System and the Metabolic Syndrome
• Mechanisms Underlying Metabolic Syndrome in Obesity
• Effects of Fish Oils on Inflammation and Insulin Resistance
• Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
• Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
• A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
• MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)
• Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
• Physical Inactivity and Insulin Resistance in Skeletal Muscle.
• Metabolic Profile and Anthropometric Changes in Schizophrenia
• Do Antidepressants Induce Metabolic Syndromes METADAP Study
• The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome
• Diurnal Variation of Plasminogen Activator Inhibitor-1
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
• A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
• Effect of a Fibrate and a Statin on Endothelial Dysfunction
• ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome
• Effect of Testosterone Replacement on Insulin Resistance
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
• Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
• Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
• The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
• Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
• Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
• Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
• Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
• Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
• Metabolic Syndrome in PCOS: Precursors and Interventions
• Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
• Insulin Sensitivity in Men With the Metabolic Syndrome
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
• Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
• Study of TNF-Antagonism in the Metabolic Syndrome (II)
• Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
• Study of TNF-Antagonism in Metabolic Syndrome
• Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity
• The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.
• The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
• Lifestyle Modification and Metformin Use in the Treatment of HIV
• ROMEO (Rosuvastatin in Metabolic syndrOme)
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
• Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
• Testosterone Effects on Men With the Metabolic Syndrome
• 11ß-HSD1 and Metabolic Syndrome
• Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
• Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
• Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults
• A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
• The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
• Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
• Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
• A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism
• The Effects of Cilnidipine on Metabolic Syndrome Improvement
• The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
• Effect of Growth Hormone in Metabolic Syndrome
• Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes
• Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
• Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
• VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt
• PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome
• Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
• Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
• Niacin, N-3 Fatty Acids and Insulin Resistance
• Integrating the Genetic and Metabolic Faces of Obesity
• Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
• Study In Patients With Dyslipidaemia
• Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
• Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
• A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
• Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
• Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant
• Rosiglitazone Versus Placebo in Chronic Stable Angina
• The Effects of Aripiprazole on Patients With Metabolic Syndrome
• Oral Contraceptives in the Metabolic Syndrome
• Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
• Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
• A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
• The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
• Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
• Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
• MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
• Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
• Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
• Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
• Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
• Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
• Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome
• Chromium Picolinate for the Treatment of Metabolic Syndrome
• Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
• Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
• Ginkgo Biloba Extract and the Insulin Resistance Syndrome